v3.25.1
PROLEUKIN ACQUISITION (Tables)
3 Months Ended
Mar. 31, 2025
PROLEUKIN ACQUISITION  
Schedule of the total cash consideration and allocated acquisition date fair values of assets acquired and liabilities assumed

The following table summarizes the total cash consideration and allocated acquisition date fair values of assets acquired and liabilities assumed at the time of the acquisition (in thousands):

Amounts

Cash

$

35

Inventory

9,688

Developed technology

232,665

Assembled workforce

636

Deferred tax liability

(20,352)

Total Cost of Acquisition

$

222,672